SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes

Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock

Melio names Boaz BenDavid as its first Chief Financial Officer

Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform

Buzz

Most popular

Daily

Weekly

1

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

2

Nvidia continues Israel shopping spree with acquisition of Deci

3

Nvidia announces $700 million acquisition of Run:ai

4

Nvidia on verge of completing $700 million acquisition of Run:ai

5

Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes

Quris

7 stories about Quris

Michel Yossi Quris

Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles

Vounatsos was appointed Board member and Ben Amram was appointed President, respectively.

ד״ר צחון בנטואיץ׳ מייסד משותף של קיוריס Quris AI

Pharma giant Merck expands collaboration with Quris-AI

28.09.23|Meir Orbach

This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches

יוסי הרן צחון בנטואיץ Quris

SoftBank leads $9 million investment in AI pharma startup Quris

20.12.22|Meir Orbach

The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials

Isaac Bentwich BiblioTech

CTech’s Book Review: Breaking down the barriers to set you free

13.07.22|Isaac Bentwich

Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer

מימין אהרון צ'חנובר יו"ר הוועדה המדעית בקיוריס והמנכ"ל צחון בנטואיץ'

Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction

09.02.22|Meir Orbach

The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant

Quris Isaac Bentwich

Quris closes record $28 million Seed funding for AI drug development platform

11.01.22|Meir Orbach

The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing

Quris Isaac Bentwich

Quris raises $9 million in Seed for its clinician prediction AI platform

21.10.21|James Spiro

The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.